Gilead Sciences gives hope for coronavirus treatment with latest data

Credit: Proactive Investors- Published on April 17, 2020
A report that Gilead Sciences INC (NASDAQ:GILD) antiviral medication remdesivir is proving effective in treating severe COVID-19 patients has raised hopes of a possible solution to the pandemic. Shares in the US giant rocketed 18% in after-hours trading adding US$14bn in its value after the story appeared in US medical...

Video credit: Cheddar Inc.
Published on April 17, 2020 -  00:19
Gilead Sciences Antiviral Drug Trial Relieving Coronavirus Patients
According to STAT News, a hospital in Chicago treating COVID-19 patients with an antiviral treatment created by Gilead Sciences has seen them quickly recover from fevers and respiratory issues. It has even been able to discharge patients from the hospital within just a week.

You are here

Related videos from verified sources

Nothing To See Here? Florida Bans Release Of COVID-19 Death Statistics 00:38
Credit: Wochit - Published on April 30, 2020 

Nearly 10% of Americans Say Even If They Think They Have COVID-19 They Would Skip Treatment Due to Costs 00:46
Credit: Veuer - Published on April 30, 2020 

Remdesivir trial shows it is an effective treatment 00:38
Credit: KTNV Channel 13 Las Vegas - Published on April 30, 2020 

Related news from verified sources

Gilead Sciences Inc (NASDAQ:GILD) said studies for the use of its antiviral drug remdesivir in patients with severe coronavirus are still inconclusive. Hopes for...
on April 24, 2020 • Proactive Investors

The Japanese stock market, which resumed trading after a holiday on Wednesday, is sharply higher following the positive cues overnight from Wall Street on...
on April 30, 2020 • RTTNews

Gilead Sciences Inc (NASDAQ:GILD) has posted positive data on the use of its antiviral agent remdesivir for severe coronavirus (Covid-19) patients. The US pharma...
on April 29, 2020 • Proactive Investors

You might like